INHIBITION OF OXIDATIVE DRUG-METABOLISM BY BETA-ADRENOCEPTOR ANTAGONISTS IS RELATED TO THEIR LIPID SOLUBILITY

被引：48

作者：

DEACON, CS ^{[1
]}

LENNARD, MS ^{[1
]}

BAX, NDS ^{[1
]}

WOODS, HF ^{[1
]}

TUCKER, GT ^{[1
]}

机构：

[1] UNIV SHEFFIELD,ROYAL HALLAMSHIRE HOSP,DEPT THERAPEUT,SHEFFIELD S10 2JF,ENGLAND

来源：

关键词：

D O I：

10.1111/j.1365-2125.1981.tb01240.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：429 / 431

页数：3

共 18 条

[1] BAX NDS, 1980, BRIT J CLIN PHARMACO, V10, P353
[2] BAX NDS, 1980, 1ST WORLD C CLIN PHA
[3] BAX NDS, BRIT J CLIN PHARMAC
[4] EFFECTS OF METOPROLOL AND PROPRANOLOL ON THEOPHYLLINE ELIMINATION
CONRAD, KA
NYMAN, DW
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (04) : 463 - 467
[5] FACINO RM, 1979, PHARMACOL RES COMMUN, V11, P433
[6] IMPAIRMENT OF ANTIPYRINE CLEARANCE IN HUMANS BY PROPRANOLOL
GREENBLATT, DJ
FRANKE, K
HUFFMAN, DH
[J]. CIRCULATION, 1978, 57 (06) : 1161 - 1164
[7] IS THERE A RELATIONSHIP BETWEEN THE PHYSICAL-PROPERTIES AND CARDIOSELECTIVITY OF BETA-ADRENOCEPTOR ANTAGONISTS
JACK, DB
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (04) : 402 - 406
[8] JOHNSSON G, 1976, Clinical Pharmacokinetics, V1, P233
[9] LACK OF BIOLOGICAL INTERACTION OF ALPRENOLOL AND SALICYLATE IN MAN
JOHNSSON, G
REGARDH, CG
SOLVELL, L
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 6 (01) : 9 - 14
[10] KEENAGHAN J B, 1972, Journal of Pharmacology and Experimental Therapeutics, V180, P454